Our Original Stem Cell Safety Paper has been Declared in the Top 1% of Papers in it’s Area
Our original stem cell safety paper was just declared in the top 1% of the papers in it’s field. This means that it’s been cited by more than 20 other papers as research of authority. This is on the heels of it’s successor paper that again looked at stem cell safety in the same patients and the outcomes of knee stem cell injections being named the best of it’s kind in stem cell joint injection papers. We’re proud of our Regenexx Research team and want to note that these distinctions point to the time, effort, and energy we have placed on our research efforts. This is very rare in the stem cell field, where 99.99% of the practicing physicians aren’t performing or publishing any research.
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.